Hims & Hers Health, Inc. (HIMS) — closed signal from November 20, 2025
Partial Published before the outcome was known, scored automatically when the window closed on February 18, 2026.
Predicted vs. what happened
What happened
Reached 64% of the predicted growth at its peak, without hitting the target.
The thesis — published November 20, 2025
Hims & Hers has dropped hard and looks washed out, which often leads to a short-term bounce. A new $250 million plan to buy back shares shows management believes in the business and can help steady the price. Still, rivals and uneven results keep risk high, so use small positions and plan exits. If the overall market calms down, a rebound over the next three months is reasonable as sentiment improves and more buyers return after the selloff.
Primary drivers
- Sharp recent drop suggests a short-term snapback is likely soon
- Company will spend $250M buying stock, which can help price hold up
- Rivals remain tough, which could limit growth and keep swings bigger
- Use small buys and quick exits to manage risk in a choppy period
How it played out
HIMS: rebound peaked below the target
Lyra published HIMS at $36.75 on 2025-11-20 with an expected 18% short-term gain and a $43.37 target. The thesis pointed to a sharp recent drop, a possible snapback, a $250 million share buyback plan, tough rivals, uneven results, and choppy trading risk.
Inside the window, HIMS rose to $40.99 on 2025-12-05, a peak gain of 11.5%. It stayed below the $43.37 target. It ended the window at $15.84 on 2026-02-18. The thesis partly played out early, then missed on the full target and finish.
What happened during the window
On 2026-02-07, Investor's Business Daily reported that Hims & Hers had stopped offering access to a compounded oral Wegovy alternative after an FDA action. The report said the FDA had referred the company to the Justice Department for potential violations.
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Share this receipt
A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.